Home › Compare › PCOGF vs EPRT

PCOGF vs EPRT: Dividend Comparison 2026

PCOGF yields 22598.87% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PCOGF wins by $176567887962527563776.00M in total portfolio value
10 years
PCOGF
PCOGF
● Live price
22598.87%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$176567887962527563776.00M
Annual income
$175,044,190,467,901,770,000,000,000.00
Full PCOGF calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — PCOGF vs EPRT

📍 PCOGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPCOGFEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PCOGF + EPRT cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
PCOGF pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PCOGF
Annual income on $10K today (after 15% tax)
$1,920,903.95/yr
After 10yr DRIP, annual income (after tax)
$148,787,561,897,716,500,000,000,000.00/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, PCOGF beats the other by $148,787,561,897,716,500,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PCOGF + EPRT for your $10,000?

PCOGF: 50%EPRT: 50%
100% EPRT50/50100% PCOGF
Portfolio after 10yr
$88283943981263781888.00M
Annual income
$87,522,095,233,950,890,000,000,000.00/yr
Blended yield
99.14%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

PCOGF
No analyst data
Altman Z
91.8
Piotroski
2/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PCOGF buys
0
EPRT buys
0
No recent congressional trades found for PCOGF or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPCOGFEPRT
Forward yield22598.87% ✓3.92%
Annual dividend / share$2.00 ✓$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29% ✓
Portfolio after 10y$176567887962527563776.00M ✓$63.4K
Annual income after 10y$175,044,190,467,901,770,000,000,000.00 ✓$12,840.73
Total dividends collected$176467449724026257408.00M ✓$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: PCOGF vs EPRT ($10,000, DRIP)

YearPCOGF PortfolioPCOGF Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$2,270,587$2,259,887.01$11,205$505.18+$2.26M → PCOGF
2$481,987,478$479,557,950.40$12,672$682.46+$481.97M → PCOGF
3$95,653,925,531$95,138,198,928.81$14,490$930.48+$95653.91M → PCOGF
4$17,748,021,186,660$17,645,671,486,342.04$16,786$1,282.69+$17748021.17M → PCOGF
5$3,078,850,357,047,340$3,059,859,974,377,613.50$19,753$1,791.56+$3078850357.03M → PCOGF
6$499,379,737,853,365,100$496,085,367,971,324,400.00$23,677$2,541.64+$499379737853.34M → PCOGF
7$75,733,840,285,631,510,000$75,199,503,966,128,420,000.00$29,008$3,672.99+$75733840285631.48M → PCOGF
8$10,739,392,155,954,406,000,000$10,658,356,946,848,782,000,000.00$36,463$5,425.08+$10739392155954406.00M → PCOGF
9$1,424,016,350,117,565,000,000,000$1,412,525,200,510,693,700,000,000.00$47,238$8,221.57+$1424016350117564928.00M → PCOGF
10$176,567,887,962,527,560,000,000,000$175,044,190,467,901,770,000,000,000.00$63,385$12,840.73+$176567887962527563776.00M → PCOGF

PCOGF vs EPRT: Complete Analysis 2026

PCOGF — Stock

Pancontinental Energy NL explores for oil and gas properties in Australia, Namibia, and Kenya. The company holds interests in the PEL 37 project in Walvis Basin and the PEL 87 project in Orange Basin located in offshore Namibia; the Meeba project and Cooper Eromanga Basin located in Queensland, Australia; and the Amu Basin L6 located in Kenya. The company was formerly known as Pancontinental Oil & Gas NL and changed its name to Pancontinental Energy NL in September 2021. Pancontinental Energy NL was incorporated in 1985 and is based in West Perth, Australia.

Full PCOGF Calculator →

EPRT — REIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this PCOGF vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PCOGF vs SCHDPCOGF vs JEPIPCOGF vs OPCOGF vs KOPCOGF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.